CHF6001 has been used in trials studying the treatment of Asthma and Chronic Obstructive Pulmonary Disease. It is grouped under the following drug class(es): PDE4 inhibitors. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Benzoic acid, 3-(cyclopropylmethoxy)-4-((methylsulfonyl)amino)-, (1S)-1-(3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl)-2-(3, 5-dichloro-1-oxido-4-pyridinyl)ethyl ester, (S)-3 and 5-Dichloro-4-[2-[3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl]-2-[[3-(cyclopropylmethoxy)-4-(methylsulfonamido)benzoyl]oxy]ethyl]pyridine 1-Oxide. Its PubChem CID is 70662473.
Tranimilast
| CAS No | 1239278-59-1 |
|---|---|
| Molecular Formula | C30H30Cl2F2N2O8S |
| Molecular Weight | 687.5 g/mol |
| Synonyms | [(1S)-1-[3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl]-2-(3,5-dichloro-1-oxidopyridin-1-ium-4-yl)ethyl] 3-(cyclopropylmethoxy)-4-(methanesulfonamido)benzoate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
CHF6001 has been used in trials studying the treatment of Asthma and Chronic Obstructive Pulmonary Disease. It is grouped under the following drug class(es): PDE4 inhibitors.
The listed CAS number is 1239278-59-1.
The listed molecular formula is C30H30Cl2F2N2O8S.
The listed molecular weight is 687.5 g/mol.
[(1S)-1-[3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl]-2-(3,5-dichloro-1-oxidopyridin-1-ium-4-yl)ethyl] 3-(cyclopropylmethoxy)-4-(methanesulfonamido)benzoate.
The source lists Benzoic acid, 3-(cyclopropylmethoxy)-4-((methylsulfonyl)amino)-, (1S)-1-(3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl)-2-(3, 5-dichloro-1-oxido-4-pyridinyl)ethyl ester, (S)-3 and 5-Dichloro-4-[2-[3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl]-2-[[3-(cyclopropylmethoxy)-4-(methylsulfonamido)benzoyl]oxy]ethyl]pyridine 1-Oxide.